Tradestie Institutional Equity Comparison Engine
PEN vs NMTC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PEN Overall Edge
PEN Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Penumbra, Inc. (PEN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PEN trades at 53.1x Forward P/E with 12.1% operating margin (+15.6% YoY revenue) versus NMTC at N/M Forward P/E and -63.4% operating margin (+16.3% YoY). In options structure, PEN sits in UNCLASSIFIED (96th %ile IV; Dealer Gamma Walls on Pro) against NMTC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
PEN
PEN 53.1x vs NMTC N/M Fwd P/E
Growth & Margin Winner
PEN
Op Margin 12.1% vs -63.4% ยท YoY +15.6% vs +16.3%
Momentum & Technical Winner
PEN
1Y +12.7% vs +3.5% ยท 52W Pos 50% vs 2%
Options & Structure Winner
PEN
UNCLASSIFIED (96th %ile IV) vs UNCLASSIFIED (N/A IV)
PEN
NYSE
Penumbra, Inc.
Surgical & Medical Instruments & Apparatus
$319.12
-0.28% 1D
Market Cap
$12.6B
1M Return
-1.8%
1Y Return
+12.7%
Forward P/E
53.1x
Unified AI Score
52.2 / 100
HOLD
Tech 55.0
Fund 56.0
Flow 63.0
Mom 46.0
NMTC
NASDAQ
NeuroOne Medical Technologies Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$0.65
-3.38% 1D
Market Cap
$6.1M
1M Return
-33.46%
1Y Return
+3.49%
Forward P/E
N/M
Unified AI Score
45.5 / 100
HOLD
Tech 33.0
Fund 51.0
Flow 60.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PEN +12.7%
NMTC +3.49%
Spread: +9.21 pp (PEN Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PEN Revenue | NMTC Revenue | PEN Op. Margin | NMTC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $440M | N/A | -0.2% | N/A | PEN |
| FY2019 | $550M | N/A | 8.7% | N/A | PEN |
| FY2020 | $560M | N/A | -6.9% | N/A | PEN |
| FY2021 | $750M | $0M | -1.0% | -5735.9% | PEN |
| FY2022 | $850M | $0M | 0.7% | -5860.2% | PEN |
| FY2023 | $1.06B | $0M | 6.9% | -612.3% | PEN |
| FY2024 | $1.19B | $0M | 0.8% | -344.3% | PEN |
| FY2025 | $1.40B | $10M | 13.5% | -46.5% | PEN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PEN | NMTC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $12.6B | $6.1M | Larger Scale | PEN |
| Trailing P/E Ratio Valuation | 80.6x | N/M | Lower Multiple | PEN |
| Forward P/E Ratio Valuation | 53.1x | N/M | Lower Multiple | PEN |
| Revenue Growth (YoY) Growth | +15.6% | +16.3% | Higher Growth | NMTC |
| Operating Margin (TTM) Profitability | 12.1% | -63.4% | Higher Margin | PEN |
| Net Profit Margin Profitability | 10.1% | -59.7% | Higher Margin | PEN |
| Return on Equity (ROE) Capital Efficiency | 10.7% | -124.7% | Higher ROE | PEN |
| 52-Week Range Position Momentum | 50% ($277โ$362) | 2% ($1โ$5) | Stronger Trend | PEN |
| Beta / 30D Volatility Risk Regime | 0.10ฮฒ ยท 10% Vol | 1.55ฮฒ ยท 105% Vol | Lower Realized Risk | PEN |
| Unified Institutional Score Composite Signal | 52.2 / 100 (HOLD) | 45.5 / 100 (HOLD) | Higher Composite | PEN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PEN vs NMTC Buy Guide
PEN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
96th %ile
IV Regime
Extreme (>80th %ile)
NMTC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PEN nor NMTC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.